|
|
|
|
Anti-TNFRSF13B / TACI Antibody (aa116-132) IHC-plus™ LS-B2094
Note: This antibody replaces LS-C813, LS-C18003Most Popular TNFRSF13B / TACI Antibodies
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|
|
||||||||
|
Details
| Human TNFRSF13B / TACI | |
| Rabbit | |
| Human, Mouse (tested or 100% immunogen sequence identity) | |
| IgG Polyclonal | |
| Unconjugated | |
| Protein G purified | |
| Unmodified |
Applications
- IHC
- IHC - Paraffin (5 µg/ml)
- Western blot (5 µg/ml)
- Flow Cytometry
Specificity and Use
| Synthetic peptide from human TNFRSF13B / TACI. | |
| aa116-132 | |
| A synthetic peptide corresponding to amino acids 116-132 of human TACI. Human and mouse TACI amino acid sequences are 65% conserved in the immunogen. | |
| Immunohistochemistry: LS-B2094 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2094 was determined to be 5 ug/ml. |
Packaging
| PBS containing 0.05% sodium azide | |
| Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. | |
| For research use only. |
About TNFRSF13B / TACI
O14836
NM_012452
NP_036584.1
TNFRSF13B Antibody, CD267 antigen Antibody, CD267 Antibody, CVID2 Antibody, TNFRSF14B Antibody, CVID Antibody, TACI Antibody
TACI is one of three known receptors for BLys. Members in the TNF superfamily regulate immune responses and induce apoptosis. Two novel members in the TNF family were recently identified and designated BAFF/BLyS/TALL-1/THANK/zTNF4 and April/TALL-2, respectively. BAFF was characterized as a B cell activator since it induced B cell proliferation and immunoglobulin secretion. April regulates immunological and non-immunological cell growth.
Print This Page
Technical Help
Review This Product
|
|
Requested From:
Date Requested: 4/21/2018
Date Requested: 4/21/2018
